Adicet Bio, Inc. (ACET) has 173 open-market insider trades by 37 insiders since 2006. The most active filer is Douglas A. Roth, President & CFO +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Carl L. Gordon | Dir10% Owner | — | 2 | $11.2M | 2024-06-05 |
| Orbimed Advisors LLC | 10% Owner | — | 3 | $7.5M | 2026-04-08 |
| Andrew Sinclair | Dir | — | 1 | $7.0M | 2025-06-11 |
| Chen Schor | CEOPres | — | 12 | $3.4M | 2026-01-24 |
| Douglas A. Roth | PresCFOVP | — | 19 | $2.8M | 2017-09-07 |
| Frank Debenedittis | PresVP | — | 16 | $2.0M | 2019-02-26 |
| Albert L. Eilender | Chairman | — | 9 | $2.0M | 2018-10-04 |
| RA Capital Management, L.P. | 10% Owner | — | 1 | $1.6M | 2026-02-20 |
| Ronald Gold | Pres | — | 4 | $1.5M | 2013-05-24 |
| Satish Srinivasan | PresCOO | — | 6 | $940K | 2016-11-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Orbimed Advisors LLC | 10% Owner | Sell | $675K | 2026-04-07 |
| RA Capital Management, L.P. | 10% Owner | Buy | $1.6M | 2026-02-18 |
| Orbimed Advisors LLC | 10% Owner | Buy | $5.0M | 2025-10-08 |
| Michael Kauffman | Director | Sell | $8K | 2024-06-05 |
| Carl L. Gordon | Director & 10% Owner | Buy | $7.5M | 2024-01-25 |
| Chen Schor | President | Sell | $15K |
Companies that share insiders with ACET, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-09-28 |
| Chen Schor | President | Buy | $15K | 2023-09-28 |
| Steve Dubin | Director | Buy | $12K | 2023-06-30 |
| Carl L. Gordon | Director & 10% Owner | Buy | $3.7M | 2023-06-27 |
| Orbimed Advisors LLC | Director & 10% | Buy | $1.8M | 2023-06-27 |
| Don Healey | CTO | Sell | $34K | 2023-02-15 |
| Don Healey | CTO | Sell | $167K | 2023-02-10 |
| Blake Aftab | CSO | Sell | $146K | 2022-11-10 |
| Chen Schor | CEO & President | Sell | $1.0M | 2022-11-10 |
| Chen Schor | CEO & President | Sell | $572K | 2022-11-07 |